UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Management of ascites in cirrhosis

Journal of gastroenterology and hepatology, 2012-01, Vol.27 (1), p.11-20

Wong, Florence

2012

Link zum Volltext

Verfügbarkeit prüfen

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data

Gastroenterology (New York, N.Y. 1943), 2007-09, Vol.133 (3), p.825-834

2007

Link zum Volltext

Verfügbarkeit prüfen

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

Gut, 2012-01, Vol.61 (1), p.108-116

2012

Link zum Volltext

Verfügbarkeit prüfen

Terlipressin for hepatorenal syndrome

Current opinion in gastroenterology, 2024-05, Vol.40 (3), p.156

Wong, Florence

2024

Link zum Volltext

Verfügbarkeit prüfen

Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know

The American journal of gastroenterology, 2023-06, Vol.118 (6), p.915-920

2023

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in our understanding of hepatorenal syndrome

Nature reviews. Gastroenterology & hepatology, 2012-07, Vol.9 (7), p.382

Wong, Florence

2012

Link zum Volltext

Verfügbarkeit prüfen

The use of TIPS in chronic liver disease

Annals of hepatology, 2006-01, Vol.5 (1), p.5-15

Wong, Florence

2006

Link zum Volltext

Verfügbarkeit prüfen

The North American Study for the Treatment of Refractory Ascites

Gastroenterology (New York, N.Y. 1943), 2003-03, Vol.124 (3), p.634-641

2003

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation

Liver transplantation, 2015-03, Vol.21 (3), p.300-307

2015

Link zum Volltext

Verfügbarkeit prüfen

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

Expert review of gastroenterology & hepatology, 2019-04, Vol.13 (4), p.293-305

2019

Link zum Volltext

Verfügbarkeit prüfen

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

The New England journal of medicine, 2021-03, Vol.384 (9), p.818-828

2021

Link zum Volltext

Verfügbarkeit prüfen

Unexpected Renal and Liver Failure

The American journal of medicine, 2010-09, Vol.123 (9), p.799-801

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion

Journal of gastroenterology and hepatology, 2015-02, Vol.30 (2), p.389-395

2015

Link zum Volltext

Verfügbarkeit prüfen

The Use of E A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt

The American journal of gastroenterology, 2009-10, Vol.104 (10), p.2458-2466

2009

Link zum Volltext

Verfügbarkeit prüfen

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

Gastroenterology (New York, N.Y. 1943), 2016-06, Vol.150 (7), p.1579-1589.e2

2016

Link zum Volltext

Verfügbarkeit prüfen

Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients with Systemic Inflammatory Response Syndrome

Clinical gastroenterology and hepatology, 2017-02, Vol.15 (2), p.266-272.e1

2017

Link zum Volltext

Verfügbarkeit prüfen

Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin

Liver transplantation, 2024-04, Vol.30 (4), p.347-355

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment

Gut, 2010-03, Vol.59 (3), p.381-386

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

Journal of hepatology, 2010-08, Vol.53 (2), p.283-290

2010

Link zum Volltext

Verfügbarkeit prüfen

Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation

Transplantation, 2015-07, Vol.99 (7), p.1441

2015

Link zum Volltext

Verfügbarkeit prüfen

Improvement in Quality of Life and Decrease in Large‐Volume Paracentesis Requirements With the Automated Low‐Flow Ascites Pump

Liver transplantation, 2020-05, Vol.26 (5), p.651-661

2020

Link zum Volltext

Verfügbarkeit prüfen

Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis

The American journal of gastroenterology, 2019-07, Vol.114 (7), p.1091-1100

2019

Link zum Volltext

Verfügbarkeit prüfen

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 2005-08, Vol.129 (2), p.528-536

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis

Clinical gastroenterology and hepatology, 2016-12, Vol.14 (12), p.1821-1830.e6

2016

Link zum Volltext

Verfügbarkeit prüfen

High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of end‐stage liver disease

Liver transplantation, 2015-07, Vol.21 (7), p.881-888

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Complete

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(49)
Female
(40)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Male
(37)
Middle Aged
(34)
Gastroenterology & Hepatology
(26)
Aged
(25)
Liver Cirrhosis - Complications
(15)
Adult
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Cirrhosis
(11)
Ascites - Etiology
(9)
Gastroenterology. Liver. Pancreas. Abdomen
(9)
Other Diseases. Semiology
(9)
Abdomen
(8)
Ascites
(8)
Retrospective Studies
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of ascites in cirrhosis

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

Terlipressin for hepatorenal syndrome

Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know

Recent advances in our understanding of hepatorenal syndrome

The use of TIPS in chronic liver disease

The North American Study for the Treatment of Refractory Ascites

Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

Unexpected Renal and Liver Failure

Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion

The Use of E A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients with Systemic Inflammatory Response Syndrome

Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin

Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation

Improvement in Quality of Life and Decrease in Large‐Volume Paracentesis Requirements With the Automated Low‐Flow Ascites Pump

Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis

High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of end‐stage liver disease

Aktive Filter

Suchergebnisse filtern